ATE360034T1 - Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft - Google Patents

Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft

Info

Publication number
ATE360034T1
ATE360034T1 AT02765578T AT02765578T ATE360034T1 AT E360034 T1 ATE360034 T1 AT E360034T1 AT 02765578 T AT02765578 T AT 02765578T AT 02765578 T AT02765578 T AT 02765578T AT E360034 T1 ATE360034 T1 AT E360034T1
Authority
AT
Austria
Prior art keywords
metastin
derivative
antibody
antibodies
specifically
Prior art date
Application number
AT02765578T
Other languages
English (en)
Inventor
Hirokazu Matsumoto
Yasuko Horikoshi
Chieko Kitada
Tetsuya Ohtaki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE360034T1 publication Critical patent/ATE360034T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02765578T 2001-09-19 2002-09-18 Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft ATE360034T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001285853 2001-09-19

Publications (1)

Publication Number Publication Date
ATE360034T1 true ATE360034T1 (de) 2007-05-15

Family

ID=19108930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765578T ATE360034T1 (de) 2001-09-19 2002-09-18 Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft

Country Status (6)

Country Link
US (2) US7112662B2 (de)
EP (1) EP1428835B1 (de)
AT (1) ATE360034T1 (de)
CA (1) CA2460803A1 (de)
DE (1) DE60219645T2 (de)
WO (1) WO2003027149A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1761680A (zh) 2002-12-26 2006-04-19 武田药品工业株式会社 肿瘤迁移抑制素衍生物及其用途
WO2004065629A1 (en) * 2003-01-17 2004-08-05 The Chinese University Of Hong Kong Circulating mrna as diagnostic markers for pregnancy-related disorders
CA2518541C (en) 2003-03-12 2013-05-21 Takeda Pharmaceutical Company Limited Gonadal function improving agents
CA2571420A1 (en) * 2004-06-25 2006-01-05 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
DE102006015001A1 (de) * 2006-03-31 2007-10-11 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren zum Nachweis und/oder zur Anreicherung von Analytproteinen und/oder Analytpeptiden aus einer komplexen Proteinmischung
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
LT2314609T (lt) * 2008-07-30 2017-04-10 Takeda Pharmaceutical Company Limited Metastino darinys ir jo panaudojimas
EP2340047A1 (de) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymerkonjugate von kiss1-peptiden
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
EP3557605B1 (de) * 2011-11-23 2021-07-14 Quest Diagnostics Investments Incorporated Kisspeptin-54 nachweis durch tandem-massenspektrometrie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762601B3 (fr) * 1997-04-29 1999-06-04 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations
JP4486187B2 (ja) * 1998-10-27 2010-06-23 武田薬品工業株式会社 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
AU2001244609A1 (en) * 2000-03-30 2001-10-15 Takeda Chemical Industries Ltd. Novel protein, dna thereof and process for producing the same
AU2001277986A1 (en) * 2000-07-25 2002-02-05 Axcell Biosciences Corporation Identification and isolation of novel polypeptides having pdz domains and methods of using same

Also Published As

Publication number Publication date
US7691979B2 (en) 2010-04-06
DE60219645T2 (de) 2007-08-09
EP1428835A1 (de) 2004-06-16
CA2460803A1 (en) 2003-04-03
DE60219645D1 (de) 2007-05-31
US20060275286A1 (en) 2006-12-07
EP1428835A4 (de) 2005-09-28
WO2003027149A1 (fr) 2003-04-03
US7112662B2 (en) 2006-09-26
US20040236077A1 (en) 2004-11-25
EP1428835B1 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
DK1571970T3 (da) Diagnose og monitorering af sygdomme
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
WO2007127977A3 (en) Methods of evaluating peptide mixtures
DE60322188D1 (de) Zytokin (zcytor17-ligand)
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
DE69841037D1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
BRPI0616712B8 (pt) método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas
EP2251356A3 (de) Polyklonale-monoklonale ELISA Bestimmung zum Nachweis von N-terminalen proBNP
DK1336109T3 (da) Kit og fremgangsmåde til at påvise proteinet EMS-1
Fischer et al. Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
EP1560025A3 (de) Marker spezifisch für Diabetes
WO2002008245A3 (en) Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
ATE371192T1 (de) Diagnose von autismus
US20110028409A1 (en) Detection of anti-ribosomal p protein antibodies by means of synthetic peptides
WO2002102847A1 (fr) Nouveau ligand et son adn
CA2597545A1 (en) Antibody for assay of adamts13 activity and method for assaying the activity
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide
WO2006038101A3 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
DE60308176D1 (de) Vorrichtung von peptid- oder proteindarstellung, verfahren zu deren herstellung und deren verwendung
WO2003027150A1 (fr) Anticorps et son utilisation
TW200702337A (en) Coronavirus S peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties